{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T16:29:35Z","timestamp":1782491375805,"version":"3.54.5"},"reference-count":137,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2021,2,24]],"date-time":"2021-02-24T00:00:00Z","timestamp":1614124800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,2,24]],"date-time":"2021-02-24T00:00:00Z","timestamp":1614124800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100000156","name":"Fonds de Recherche du Qu\u00e9bec - Sant\u00e9","doi-asserted-by":"publisher","award":["35059"],"award-info":[{"award-number":["35059"]}],"id":[{"id":"10.13039\/501100000156","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000156","name":"Fonds de Recherche du Qu\u00e9bec - Sant\u00e9","doi-asserted-by":"publisher","award":["260387"],"award-info":[{"award-number":["260387"]}],"id":[{"id":"10.13039\/501100000156","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["PJT-162164"],"award-info":[{"award-number":["PJT-162164"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["PJT-168865"],"award-info":[{"award-number":["PJT-168865"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["201910MFE-430883-231775"],"award-info":[{"award-number":["201910MFE-430883-231775"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1007\/s00415-021-10418-8","type":"journal-article","created":{"date-parts":[[2021,2,24]],"date-time":"2021-02-24T12:03:09Z","timestamp":1614168189000},"page":"3493-3504","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Huntington\u2019s disease: lessons from prion disorders"],"prefix":"10.1007","volume":"268","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2782-5454","authenticated-orcid":false,"given":"Melanie","family":"Alpaugh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5490-1961","authenticated-orcid":false,"given":"Francesca","family":"Cicchetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,2,24]]},"reference":[{"issue":"39","key":"10418_CR1","doi-asserted-by":"publisher","first-page":"E5427","DOI":"10.1073\/pnas.1516217112","volume":"112","author":"DT Babcock","year":"2015","unstructured":"Babcock DT, Ganetzky B (2015) Transcellular spreading of huntingtin aggregates in the Drosophila brain. PNAS 112(39):E5427\u2013E5433. https:\/\/doi.org\/10.1073\/pnas.1516217112","journal-title":"PNAS"},{"issue":"6","key":"10418_CR2","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1007\/s00401-019-01973-6","volume":"137","author":"M Masnata","year":"2019","unstructured":"Masnata M, Sciacca G, Maxan A, Bousset L, Denis HL, Lauruol F, David L, Saint-Pierre M, Kordower JH, Melki R, Alpaugh M, Cicchetti F (2019) Demonstration of prion-like properties of mutant huntingtin fibrils in both in vitro and in vivo paradigms. Acta Neuropathol 137(6):981\u20131001. https:\/\/doi.org\/10.1007\/s00401-019-01973-6","journal-title":"Acta Neuropathol"},{"key":"10418_CR3","doi-asserted-by":"publisher","first-page":"104941","DOI":"10.1016\/j.nbd.2020.104941","volume":"141","author":"P Gosset","year":"2020","unstructured":"Gosset P, Maxan A, Alpaugh M, Breger L, Dehay B, Tao Z, Ling Z, Qin C, Cisbani G, Fortin N, Vonsattel JG, Lacroix S, Oueslati A, Bezard E, Cicchetti F (2020) Evidence for the spread of human-derived mutant huntingtin protein in mice and non-human primates. Neurobiol Dis 141:104941. https:\/\/doi.org\/10.1016\/j.nbd.2020.104941","journal-title":"Neurobiol Dis"},{"key":"10418_CR4","doi-asserted-by":"publisher","unstructured":"Rieux M, Alpaugh M, Sciacca G, Saint-Pierre M, Masnata M, Denis HL, Levesque SA, Herrmann F, Bazenet C, Garneau AP, Isenring P, Truant R, Oueslati A, Gould PV, Ast A, Wanker EE, Lacroix S, Cicchetti F (2020) Shedding a new light on Huntington's disease: how blood can both propagate and ameliorate disease pathology. Mol Psychiatry. Epub ahead of print. https:\/\/doi.org\/10.1038\/s41380-020-0787-4. Erratum in: Mol Psychiatry. 2020 Jul 24: PMID: 32514103","DOI":"10.1038\/s41380-020-0787-4"},{"issue":"4","key":"10418_CR5","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1007\/s00401-016-1582-9","volume":"132","author":"I Jeon","year":"2016","unstructured":"Jeon I, Cicchetti F, Cisbani G, Lee S, Li E, Bae J, Lee N, Li L, Im W, Kim M, Kim HS, Oh SH, Kim TA, Ko JJ, Aube B, Oueslati A, Kim YJ, Song J (2016) Human-to-mouse prion-like propagation of mutant huntingtin protein. Acta Neuropathol 132(4):577\u2013592. https:\/\/doi.org\/10.1007\/s00401-016-1582-9","journal-title":"Acta Neuropathol"},{"issue":"5","key":"10418_CR6","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.molcel.2018.07.032","volume":"71","author":"A Ast","year":"2018","unstructured":"Ast A, Buntru A, Schindler F, Hasenkopf R, Schulz A, Brusendorf L, Klockmeier K, Grelle G, McMahon B, Niederlechner H, Jansen I, Diez L, Edel J, Boeddrich A, Franklin SA, Baldo B, Schnoegl S, Kunz S, Purfurst B, Gaertner A, Kampinga HH, Morton AJ, Petersen A, Kirstein J, Bates GP, Wanker EE (2018) mHTT Seeding Activity: A Marker of Disease Progression and Neurotoxicity in Models of Huntington\u2019s Disease. Mol Cell 71(5):675-688 e676. https:\/\/doi.org\/10.1016\/j.molcel.2018.07.032","journal-title":"Mol Cell"},{"issue":"6","key":"10418_CR7","doi-asserted-by":"publisher","first-page":"321","DOI":"10.5607\/en.2017.26.6.321","volume":"26","author":"DK Kim","year":"2017","unstructured":"Kim DK, Cho KW, Ahn WJ, Perez-Acuna D, Jeong H, Lee HJ, Lee SJ (2017) Cell-to-cell transmission of polyglutamine aggregates in C. elegans. Exp Neurobiol 26(6):321\u2013328. https:\/\/doi.org\/10.5607\/en.2017.26.6.321","journal-title":"Exp Neurobiol"},{"issue":"13","key":"10418_CR8","doi-asserted-by":"publisher","first-page":"9982","DOI":"10.1074\/jbc.M111.305417","volume":"287","author":"S Gupta","year":"2012","unstructured":"Gupta S, Jie S, Colby DW (2012) Protein misfolding detected early in pathogenesis of transgenic mouse model of Huntington disease using amyloid seeding assay. J Biol Chem 287(13):9982\u20139989. https:\/\/doi.org\/10.1074\/jbc.M111.305417","journal-title":"J Biol Chem"},{"issue":"11","key":"10418_CR9","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1038\/mp.2015.81","volume":"20","author":"Z Tan","year":"2015","unstructured":"Tan Z, Dai W, van Erp TG, Overman J, Demuro A, Digman MA, Hatami A, Albay R, Sontag EM, Potkin KT, Ling S, Macciardi F, Bunney WE, Long JD, Paulsen JS, Ringman JM, Parker I, Glabe C, Thompson LM, Chiu W, Potkin SG (2015) Huntington\u2019s disease cerebrospinal fluid seeds aggregation of mutant huntingtin. Mol Psychiatry 20(11):1286\u20131293. https:\/\/doi.org\/10.1038\/mp.2015.81","journal-title":"Mol Psychiatry"},{"issue":"5940","key":"10418_CR10","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1038\/306234a0","volume":"306","author":"JF Gusella","year":"1983","unstructured":"Gusella JF, Wexler NS, Conneally PM, Naylor SL, Anderson MA, Tanzi RE, Watkins PC, Ottina K, Wallace MR, Sakaguchi AY et al (1983) A polymorphic DNA marker genetically linked to Huntington\u2019s disease. Nature 306(5940):234\u2013238. https:\/\/doi.org\/10.1038\/306234a0","journal-title":"Nature"},{"issue":"6","key":"10418_CR11","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1016\/j.ajhg.2019.04.007","volume":"104","author":"GEB Wright","year":"2019","unstructured":"Wright GEB, Collins JA, Kay C, McDonald C, Dolzhenko E, Xia Q, Becanovic K, Drogemoller BI, Semaka A, Nguyen CM, Trost B, Richards F, Bijlsma EK, Squitieri F, Ross CJD, Scherer SW, Eberle MA, Yuen RKC, Hayden MR (2019) Length of uninterrupted CAG, independent of polyglutamine size, results in increased somatic instability, hastening onset of Huntington disease. Am J Hum Genet 104(6):1116\u20131126. https:\/\/doi.org\/10.1016\/j.ajhg.2019.04.007","journal-title":"Am J Hum Genet"},{"issue":"4","key":"10418_CR12","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1016\/j.cell.2019.06.036","volume":"178","author":"Genetic Modifiers of Huntington's Disease Consortium","year":"2019","unstructured":"Genetic Modifiers of Huntington\u2019s Disease Consortium (2019) CAG repeat not polyglutamine length determines timing of Huntington\u2019s disease onset. Cell 178(4):887-900 e814. https:\/\/doi.org\/10.1016\/j.cell.2019.06.036","journal-title":"Cell"},{"issue":"10","key":"10418_CR13","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.1093\/hmg\/4.10.1911","volume":"4","author":"YP Goldberg","year":"1995","unstructured":"Goldberg YP, McMurray CT, Zeisler J, Almqvist E, Sillence D, Richards F, Gacy AM, Buchanan J, Telenius H, Hayden MR (1995) Increased instability of intermediate alleles in families with sporadic Huntington disease compared to similar sized intermediate alleles in the general population. Hum Mol Genet 4(10):1911\u20131918. https:\/\/doi.org\/10.1093\/hmg\/4.10.1911","journal-title":"Hum Mol Genet"},{"issue":"2","key":"10418_CR14","doi-asserted-by":"publisher","first-page":"217","DOI":"10.3233\/JPD-150543","volume":"5","author":"R Melki","year":"2015","unstructured":"Melki R (2015) Role of different alpha-synuclein strains in synucleinopathies, similarities with other neurodegenerative diseases. J Parkinsons Dis 5(2):217\u2013227. https:\/\/doi.org\/10.3233\/JPD-150543","journal-title":"J Parkinsons Dis"},{"issue":"7556","key":"10418_CR15","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1038\/nature14547","volume":"522","author":"W Peelaerts","year":"2015","unstructured":"Peelaerts W, Bousset L, Van der Perren A, Moskalyuk A, Pulizzi R, Giugliano M, Van den Haute C, Melki R, Baekelandt V (2015) alpha-Synuclein strains cause distinct synucleinopathies after local and systemic administration. Nature 522(7556):340\u2013344. https:\/\/doi.org\/10.1038\/nature14547","journal-title":"Nature"},{"issue":"38","key":"10418_CR16","doi-asserted-by":"publisher","first-page":"E5308","DOI":"10.1073\/pnas.1514475112","volume":"112","author":"SB Prusiner","year":"2015","unstructured":"Prusiner SB, Woerman AL, Mordes DA, Watts JC, Rampersaud R, Berry DB, Patel S, Oehler A, Lowe JK, Kravitz SN, Geschwind DH, Glidden DV, Halliday GM, Middleton LT, Gentleman SM, Grinberg LT, Giles K (2015) Evidence for alpha-synuclein prions causing multiple system atrophy in humans with parkinsonism. PNAS 112(38):E5308-5317. https:\/\/doi.org\/10.1073\/pnas.1514475112","journal-title":"PNAS"},{"issue":"3","key":"10418_CR17","doi-asserted-by":"publisher","first-page":"261","DOI":"10.3390\/v11030261","volume":"11","author":"C Scialo","year":"2019","unstructured":"Scialo C, De Cecco E, Manganotti P, Legname G (2019) Prion and prion-like protein strains: deciphering the molecular basis of heterogeneity in neurodegeneration. Viruses 11(3):261. https:\/\/doi.org\/10.3390\/v11030261","journal-title":"Viruses"},{"key":"10418_CR18","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1186\/1743-422X-8-559","volume":"8","author":"M Imran","year":"2011","unstructured":"Imran M, Mahmood S (2011) An overview of human prion diseases. Virol J 8:559. https:\/\/doi.org\/10.1186\/1743-422X-8-559","journal-title":"Virol J"},{"issue":"3","key":"10418_CR19","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1111\/j.1423-0410.2006.00833.x","volume":"91","author":"PE Hewitt","year":"2006","unstructured":"Hewitt PE, Llewelyn CA, Mackenzie J, Will RG (2006) Creutzfeldt-Jakob disease and blood transfusion: results of the UK transfusion medicine epidemiological review study. Vox Sang 91(3):221\u2013230. https:\/\/doi.org\/10.1111\/j.1423-0410.2006.00833.x","journal-title":"Vox Sang"},{"issue":"2","key":"10418_CR20","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1111\/j.1574-695X.1998.tb01153.x","volume":"21","author":"JW Ironside","year":"1998","unstructured":"Ironside JW (1998) Neuropathological findings in new variant CJD and experimental transmission of BSE. FEMS Immunol Med Microbiol 21(2):91\u201395. https:\/\/doi.org\/10.1111\/j.1574-695X.1998.tb01153.x","journal-title":"FEMS Immunol Med Microbiol"},{"issue":"2","key":"10418_CR21","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/s0022-510x(98)00226-3","volume":"160","author":"CJ Lang","year":"1998","unstructured":"Lang CJ, Heckmann JG, Neundorfer B (1998) Creutzfeldt\u2013Jakob disease via dural and corneal transplants. J Neurol Sci 160(2):128\u2013139. https:\/\/doi.org\/10.1016\/s0022-510x(98)00226-3","journal-title":"J Neurol Sci"},{"issue":"1","key":"10418_CR22","doi-asserted-by":"publisher","first-page":"E10","DOI":"10.3171\/2016.5.FOCUS15126","volume":"41","author":"DJ Bonda","year":"2016","unstructured":"Bonda DJ, Manjila S, Mehndiratta P, Khan F, Miller BR, Onwuzulike K, Puoti G, Cohen ML, Schonberger LB, Cali I (2016) Human prion diseases: surgical lessons learned from iatrogenic prion transmission. Neurosurg Focus 41(1):E10. https:\/\/doi.org\/10.3171\/2016.5.FOCUS15126","journal-title":"Neurosurg Focus"},{"issue":"3","key":"10418_CR23","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1056\/NEJMc1610003","volume":"376","author":"T Mok","year":"2017","unstructured":"Mok T, Jaunmuktane Z, Joiner S, Campbell T, Morgan C, Wakerley B, Golestani F, Rudge P, Mead S, Jager HR, Wadsworth JD, Brandner S, Collinge J (2017) Variant Creutzfeldt-Jakob disease in a patient with heterozygosity at PRNP codon 129. N Engl J Med 376(3):292\u2013294. https:\/\/doi.org\/10.1056\/NEJMc1610003","journal-title":"N Engl J Med"},{"key":"10418_CR24","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1186\/1471-2350-10-146","volume":"10","author":"MT Bishop","year":"2009","unstructured":"Bishop MT, Pennington C, Heath CA, Will RG, Knight RS (2009) PRNP variation in UK sporadic and variant Creutzfeldt Jakob disease highlights genetic risk factors and a novel non-synonymous polymorphism. BMC Med Genet 10:146. https:\/\/doi.org\/10.1186\/1471-2350-10-146","journal-title":"BMC Med Genet"},{"issue":"2","key":"10418_CR25","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1002\/1531-8249(199908)46:2<224::AID-ANA12>3.0.CO;2-W","volume":"46","author":"P Parchi","year":"1999","unstructured":"Parchi P, Giese A, Capellari S, Brown P, Schulz-Schaeffer W, Windl O, Zerr I, Budka H, Kopp N, Piccardo P, Poser S, Rojiani A, Streichemberger N, Julien J, Vital C, Ghetti B, Gambetti P, Kretzschmar H (1999) Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects. Ann Neurol 46(2):224\u2013233","journal-title":"Ann Neurol"},{"key":"10418_CR26","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.neulet.2018.01.014","volume":"668","author":"Y Munesue","year":"2018","unstructured":"Munesue Y, Shimazaki T, Qi Z, Isoda N, Sawa H, Aoshima K, Kimura T, Mohri S, Kitamoto T, Kobayashi A (2018) Development of a quick bioassay for the evaluation of transmission properties of acquired prion diseases. Neurosci Lett 668:43\u201347. https:\/\/doi.org\/10.1016\/j.neulet.2018.01.014","journal-title":"Neurosci Lett"},{"issue":"5","key":"10418_CR27","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1002\/ana.410350504","volume":"35","author":"P Brown","year":"1994","unstructured":"Brown P, Gibbs CJ Jr, Rodgers-Johnson P, Asher DM, Sulima MP, Bacote A, Goldfarb LG, Gajdusek DC (1994) Human spongiform encephalopathy: the National Institutes of Health series of 300 cases of experimentally transmitted disease. Ann Neurol 35(5):513\u2013529. https:\/\/doi.org\/10.1002\/ana.410350504","journal-title":"Ann Neurol"},{"issue":"1510","key":"10418_CR28","doi-asserted-by":"publisher","first-page":"3747","DOI":"10.1098\/rstb.2008.0069","volume":"363","author":"JD Wadsworth","year":"2008","unstructured":"Wadsworth JD, Joiner S, Linehan JM, Asante EA, Brandner S, Collinge J (2008) Review. The origin of the prion agent of kuru: molecular and biological strain typing. Philos Trans R Soc Lond B Biol Sci 363(1510):3747\u20133753. https:\/\/doi.org\/10.1098\/rstb.2008.0069","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"issue":"1","key":"10418_CR29","doi-asserted-by":"publisher","first-page":"73","DOI":"10.3201\/eid2501.180807","volume":"25","author":"R Nonno","year":"2019","unstructured":"Nonno R, Notari S, Di Bari MA, Cali I, Pirisinu L, d\u2019Agostino C, Cracco L, Kofskey D, Vanni I, Lavrich J, Parchi P, Agrimi U, Gambetti P (2019) Variable protease-sensitive prionopathy transmission to bank voles. Emerg Infect Dis 25(1):73\u201381. https:\/\/doi.org\/10.3201\/eid2501.180807","journal-title":"Emerg Infect Dis"},{"issue":"1","key":"10418_CR30","doi-asserted-by":"publisher","first-page":"31","DOI":"10.3109\/01913123.2010.527038","volume":"35","author":"PP Liberski","year":"2011","unstructured":"Liberski PP, Sikorska B, Gibson P, Brown P (2011) Autophagy contributes to widespread neuronal degeneration in hamsters infected with the Echigo-1 strain of Creutzfeldt-Jakob disease and mice infected with the Fujisaki strain of Gerstmann-Straussler-Scheinker (GSS) syndrome. Ultrastruct Pathol 35(1):31\u201336. https:\/\/doi.org\/10.3109\/01913123.2010.527038","journal-title":"Ultrastruct Pathol"},{"key":"10418_CR31","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/bs.pmbts.2017.06.014","volume":"150","author":"A Marin-Moreno","year":"2017","unstructured":"Marin-Moreno A, Fernandez-Borges N, Espinosa JC, Andreoletti O, Torres JM (2017) Transmission and replication of prions. Prog Mol Biol Transl Sci 150:181\u2013201. https:\/\/doi.org\/10.1016\/bs.pmbts.2017.06.014","journal-title":"Prog Mol Biol Transl Sci"},{"issue":"21","key":"10418_CR32","doi-asserted-by":"publisher","first-page":"9936","DOI":"10.1073\/pnas.91.21.9936","volume":"91","author":"GC Telling","year":"1994","unstructured":"Telling GC, Scott M, Hsiao KK, Foster D, Yang SL, Torchia M, Sidle KC, Collinge J, DeArmond SJ, Prusiner SB (1994) Transmission of Creutzfeldt-Jakob disease from humans to transgenic mice expressing chimeric human-mouse prion protein. PNAS 91(21):9936\u20139940. https:\/\/doi.org\/10.1073\/pnas.91.21.9936","journal-title":"PNAS"},{"key":"10418_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.nbd.2018.07.011","volume":"119","author":"J Sanchez-Garcia","year":"2018","unstructured":"Sanchez-Garcia J, Fernandez-Funez P (2018) D159 and S167 are protective residues in the prion protein from dog and horse, two prion-resistant animals. Neurobiol Dis 119:1\u201312. https:\/\/doi.org\/10.1016\/j.nbd.2018.07.011","journal-title":"Neurobiol Dis"},{"issue":"4","key":"10418_CR34","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1016\/j.neuron.2016.09.055","volume":"92","author":"SK Kaufman","year":"2016","unstructured":"Kaufman SK, Sanders DW, Thomas TL, Ruchinskas AJ, Vaquer-Alicea J, Sharma AM, Miller TM, Diamond MI (2016) Tau prion strains dictate patterns of cell pathology, progression rate, and regional vulnerability in vivo. Neuron 92(4):796\u2013812. https:\/\/doi.org\/10.1016\/j.neuron.2016.09.055","journal-title":"Neuron"},{"issue":"7794","key":"10418_CR35","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1038\/s41586-020-1984-7","volume":"578","author":"M Shahnawaz","year":"2020","unstructured":"Shahnawaz M, Mukherjee A, Pritzkow S, Mendez N, Rabadia P, Liu X, Hu B, Schmeichel A, Singer W, Wu G, Tsai AL, Shirani H, Nilsson KPR, Low PA, Soto C (2020) Discriminating alpha-synuclein strains in Parkinson\u2019s disease and multiple system atrophy. Nature 578(7794):273\u2013277. https:\/\/doi.org\/10.1038\/s41586-020-1984-7","journal-title":"Nature"},{"issue":"1","key":"10418_CR36","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/s41593-019-0541-x","volume":"23","author":"A Lau","year":"2020","unstructured":"Lau A, So RWL, Lau HHC, Sang JC, Ruiz-Riquelme A, Fleck SC, Stuart E, Menon S, Visanji NP, Meisl G, Faidi R, Marano MM, Schmitt-Ulms C, Wang Z, Fraser PE, Tandon A, Hyman BT, Wille H, Ingelsson M, Klenerman D, Watts JC (2020) alpha-Synuclein strains target distinct brain regions and cell types. Nat Neurosci 23(1):21\u201331. https:\/\/doi.org\/10.1038\/s41593-019-0541-x","journal-title":"Nat Neurosci"},{"issue":"Pt B","key":"10418_CR37","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.nbd.2017.07.018","volume":"109","author":"C Peng","year":"2018","unstructured":"Peng C, Gathagan RJ, Lee VM (2018) Distinct alpha-Synuclein strains and implications for heterogeneity among alpha-Synucleinopathies. Neurobiol Dis 109(Pt B):209\u2013218. https:\/\/doi.org\/10.1016\/j.nbd.2017.07.018","journal-title":"Neurobiol Dis"},{"issue":"Pt 11","key":"10418_CR38","doi-asserted-by":"publisher","first-page":"3380","DOI":"10.1093\/brain\/aws230","volume":"135","author":"H Tsuji","year":"2012","unstructured":"Tsuji H, Arai T, Kametani F, Nonaka T, Yamashita M, Suzukake M, Hosokawa M, Yoshida M, Hatsuta H, Takao M, Saito Y, Murayama S, Akiyama H, Hasegawa M, Mann DM, Tamaoka A (2012) Molecular analysis and biochemical classification of TDP-43 proteinopathy. Brain 135(Pt 11):3380\u20133391. https:\/\/doi.org\/10.1093\/brain\/aws230","journal-title":"Brain"},{"issue":"28","key":"10418_CR39","doi-asserted-by":"publisher","first-page":"10323","DOI":"10.1073\/pnas.1408900111","volume":"111","author":"JC Watts","year":"2014","unstructured":"Watts JC, Condello C, Stohr J, Oehler A, Lee J, DeArmond SJ, Lannfelt L, Ingelsson M, Giles K, Prusiner SB (2014) Serial propagation of distinct strains of Abeta prions from Alzheimer\u2019s disease patients. PNAS 111(28):10323\u201310328. https:\/\/doi.org\/10.1073\/pnas.1408900111","journal-title":"PNAS"},{"key":"10418_CR40","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-020-02201-2","author":"HHC Lau","year":"2020","unstructured":"Lau HHC, Ingelsson M, Watts JC (2020) The existence of Abeta strains and their potential for driving phenotypic heterogeneity in Alzheimer\u2019s disease. Acta Neuropathol. https:\/\/doi.org\/10.1007\/s00401-020-02201-2 (Epub ahead of print)","journal-title":"Acta Neuropathol"},{"issue":"6","key":"10418_CR41","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1016\/j.addr.2003.09.006","volume":"56","author":"FP Huang","year":"2004","unstructured":"Huang FP, MacPherson GG (2004) Dendritic cells and oral transmission of prion diseases. Adv Drug Deliv Rev 56(6):901\u2013913. https:\/\/doi.org\/10.1016\/j.addr.2003.09.006","journal-title":"Adv Drug Deliv Rev"},{"issue":"2","key":"10418_CR42","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1038\/nrneurol.2014.263","volume":"11","author":"S Mead","year":"2015","unstructured":"Mead S, Reilly MM (2015) A new prion disease: relationship with central and peripheral amyloidoses. Nat Rev Neurol 11(2):90\u201397. https:\/\/doi.org\/10.1038\/nrneurol.2014.263","journal-title":"Nat Rev Neurol"},{"issue":"3","key":"10418_CR43","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/j.cjca.2019.12.033","volume":"36","author":"SAM Cuddy","year":"2020","unstructured":"Cuddy SAM, Falk RH (2020) Amyloidosis as a systemic disease in context. Can J Cardiol 36(3):396\u2013407. https:\/\/doi.org\/10.1016\/j.cjca.2019.12.033","journal-title":"Can J Cardiol"},{"issue":"2","key":"10418_CR44","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1177\/0300985813511128","volume":"51","author":"T Murakami","year":"2014","unstructured":"Murakami T, Ishiguro N, Higuchi K (2014) Transmission of systemic AA amyloidosis in animals. Vet Pathol 51(2):363\u2013371. https:\/\/doi.org\/10.1177\/0300985813511128","journal-title":"Vet Pathol"},{"issue":"3","key":"10418_CR45","doi-asserted-by":"publisher","first-page":"898","DOI":"10.2353\/ajpath.2006.050350","volume":"168","author":"T Korenaga","year":"2006","unstructured":"Korenaga T, Yan J, Sawashita J, Matsushita T, Naiki H, Hosokawa M, Mori M, Higuchi K, Fu X (2006) Transmission of amyloidosis in offspring of mice with AApoAII amyloidosis. Am J Pathol 168(3):898\u2013906. https:\/\/doi.org\/10.2353\/ajpath.2006.050350","journal-title":"Am J Pathol"},{"issue":"4","key":"10418_CR46","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1136\/jnnp-2018-319221","volume":"90","author":"S Baiardi","year":"2019","unstructured":"Baiardi S, Redaelli V, Ripellino P, Rossi M, Franceschini A, Moggio M, Sola P, Ladogana A, Fociani P, Magherini A, Capellari S, Giese A, Caughey B, Caroppo P, Parchi P (2019) Prion-related peripheral neuropathy in sporadic Creutzfeldt-Jakob disease. J Neurol Neurosurg Psychiatry 90(4):424\u2013427. https:\/\/doi.org\/10.1136\/jnnp-2018-319221","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"8","key":"10418_CR47","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1002\/mds.25966","volume":"29","author":"CW Olanow","year":"2014","unstructured":"Olanow CW, Wakeman DR, Kordower JH (2014) Peripheral alpha-synuclein and Parkinson\u2019s disease. Mov Disord 29(8):963\u2013966. https:\/\/doi.org\/10.1002\/mds.25966","journal-title":"Mov Disord"},{"issue":"Suppl 1","key":"10418_CR48","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1111\/jnc.13691","volume":"139","author":"S Sveinbjornsdottir","year":"2016","unstructured":"Sveinbjornsdottir S (2016) The clinical symptoms of Parkinson\u2019s disease. J Neurochem 139(Suppl 1):318\u2013324. https:\/\/doi.org\/10.1111\/jnc.13691","journal-title":"J Neurochem"},{"issue":"1","key":"10418_CR49","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1186\/s40478-019-0824-1","volume":"7","author":"F Mori","year":"2019","unstructured":"Mori F, Tada M, Kon T, Miki Y, Tanji K, Kurotaki H, Tomiyama M, Ishihara T, Onodera O, Kakita A, Wakabayashi K (2019) Phosphorylated TDP-43 aggregates in skeletal and cardiac muscle are a marker of myogenic degeneration in amyotrophic lateral sclerosis and various conditions. Acta Neuropathol Commun 7(1):165. https:\/\/doi.org\/10.1186\/s40478-019-0824-1","journal-title":"Acta Neuropathol Commun"},{"issue":"12","key":"10418_CR50","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1001\/jamaneurol.2017.2255","volume":"74","author":"BJ Murdock","year":"2017","unstructured":"Murdock BJ, Zhou T, Kashlan SR, Little RJ, Goutman SA, Feldman EL (2017) Correlation of peripheral immunity with rapid amyotrophic lateral sclerosis progression. JAMA Neurol 74(12):1446\u20131454. https:\/\/doi.org\/10.1001\/jamaneurol.2017.2255","journal-title":"JAMA Neurol"},{"issue":"14","key":"10418_CR51","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.1002\/mds.25172","volume":"27","author":"F Squitieri","year":"2012","unstructured":"Squitieri F, Jankovic J (2012) Huntington\u2019s disease: how intermediate are intermediate repeat lengths? Mov Disord 27(14):1714\u20131717. https:\/\/doi.org\/10.1002\/mds.25172","journal-title":"Mov Disord"},{"issue":"12","key":"10418_CR52","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1002\/ccr3.743","volume":"4","author":"MM Al-Mamun","year":"2016","unstructured":"Al-Mamun MM, Sarker SK, Qadri SK, Shirin T, Mohammad QD, LaRocque R, Karlsson EK, Saha N, Asaduzzaman M, Qadri F, Mannoor MK (2016) Examination of Huntington\u2019s disease with atypical clinical features in a Bangladeshi family tree. Clin Case Rep 4(12):1191\u20131194. https:\/\/doi.org\/10.1002\/ccr3.743","journal-title":"Clin Case Rep"},{"issue":"3 Pt 1","key":"10418_CR53","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1212\/wnl.45.3.443","volume":"45","author":"JW Britton","year":"1995","unstructured":"Britton JW, Uitti RJ, Ahlskog JE, Robinson RG, Kremer B, Hayden MR (1995) Hereditary late-onset chorea without significant dementia: genetic evidence for substantial phenotypic variation in Huntington\u2019s disease. Neurology 45(3 Pt 1):443\u2013447. https:\/\/doi.org\/10.1212\/wnl.45.3.443","journal-title":"Neurology"},{"issue":"5","key":"10418_CR54","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1007\/s00401-012-1005-5","volume":"124","author":"M Tada","year":"2012","unstructured":"Tada M, Coon EA, Osmand AP, Kirby PA, Martin W, Wieler M, Shiga A, Shirasaki H, Tada M, Makifuchi T, Yamada M, Kakita A, Nishizawa M, Takahashi H, Paulson HL (2012) Coexistence of Huntington\u2019s disease and amyotrophic lateral sclerosis: a clinicopathologic study. Acta Neuropathol 124(5):749\u2013760. https:\/\/doi.org\/10.1007\/s00401-012-1005-5","journal-title":"Acta Neuropathol"},{"key":"10418_CR55","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2020.11.005","author":"R Dewan","year":"2020","unstructured":"Dewan R, Chia R, Ding J, Hickman RA, Stein TD, Abramzon Y, Ahmed S, Sabir MS, Portley MK, Tucci A, Ibanez K, Shankaracharya FNU, Keagle P, Rossi G, Caroppo P, Tagliavini F, Waldo ML, Johansson PM, Nilsson CF, American Genome C, Consortium FS, Genomics England Research C, International ALSFTDGC, International FTDGC, International LBDGC, Consortium NA, Consortium P, Rowe JB, Benussi L, Binetti G, Ghidoni R, Jabbari E, Viollet C, Glass JD, Singleton AB, Silani V, Ross OA, Ryten M, Torkamani A, Tanaka T, Ferrucci L, Resnick SM, Pickering-Brown S, Brady CB, Kowal N, Hardy JA, Van Deerlin V, Vonsattel JP, Harms MB, Morris HR, Ferrari R, Landers JE, Chio A, Gibbs JR, Dalgard CL, Scholz SW, Traynor BJ (2020) Pathogenic huntingtin repeat expansions in patients with frontotemporal dementia and amyotrophic lateral sclerosis. Neuron. https:\/\/doi.org\/10.1016\/j.neuron.2020.11.005","journal-title":"Neuron"},{"issue":"11","key":"10418_CR56","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1016\/S1474-4422(15)00177-5","volume":"14","author":"JB Carroll","year":"2015","unstructured":"Carroll JB, Bates GP, Steffan J, Saft C, Tabrizi SJ (2015) Treating the whole body in Huntington\u2019s disease. Lancet Neurol 14(11):1135\u20131142. https:\/\/doi.org\/10.1016\/S1474-4422(15)00177-5","journal-title":"Lancet Neurol"},{"issue":"24","key":"10418_CR57","doi-asserted-by":"publisher","first-page":"9679","DOI":"10.1073\/pnas.0812083106","volume":"106","author":"Y Nekooki-Machida","year":"2009","unstructured":"Nekooki-Machida Y, Kurosawa M, Nukina N, Ito K, Oda T, Tanaka M (2009) Distinct conformations of in vitro and in vivo amyloids of huntingtin-exon1 show different cytotoxicity. PNAS 106(24):9679\u20139684. https:\/\/doi.org\/10.1073\/pnas.0812083106","journal-title":"PNAS"},{"key":"10418_CR58","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/B978-0-12-385883-2.00010-2","volume":"107","author":"Z Zheng","year":"2012","unstructured":"Zheng Z, Diamond MI (2012) Huntington disease and the huntingtin protein. Prog Mol Biol Transl Sci 107:189\u2013214. https:\/\/doi.org\/10.1016\/B978-0-12-385883-2.00010-2","journal-title":"Prog Mol Biol Transl Sci"},{"issue":"9","key":"10418_CR59","doi-asserted-by":"publisher","first-page":"3562","DOI":"10.1073\/pnas.1821216116","volume":"116","author":"SA Kotler","year":"2019","unstructured":"Kotler SA, Tugarinov V, Schmidt T, Ceccon A, Libich DS, Ghirlando R, Schwieters CD, Clore GM (2019) Probing initial transient oligomerization events facilitating Huntingtin fibril nucleation at atomic resolution by relaxation-based NMR. PNAS 116(9):3562\u20133571. https:\/\/doi.org\/10.1073\/pnas.1821216116","journal-title":"PNAS"},{"issue":"6","key":"10418_CR60","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1212\/WNL.0000000000002958","volume":"87","author":"PJ Morrison","year":"2016","unstructured":"Morrison PJ, Benito-Leon J (2016) Neurologic features in intermediate allele carriers of Huntington disease. Neurology 87(6):556\u2013557. https:\/\/doi.org\/10.1212\/WNL.0000000000002958","journal-title":"Neurology"},{"key":"10418_CR61","doi-asserted-by":"publisher","unstructured":"Menendez-Gonzalez M, Clarimon J, Rosas-Allende I, Blazquez M, San Martin ES, Garcia-Fernandez C, Lleo A, Dols-Icardo O, Illan-Gala I, Moris G, Ribacoba R, Alvarez V, Martinez C (2019) HTT gene intermediate alleles in neurodegeneration: evidence for association with Alzheimer's disease. Neurobiol Aging 76:215 e219\u2013215 e214. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2018.11.014","DOI":"10.1016\/j.neurobiolaging.2018.11.014"},{"key":"10418_CR62","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/B978-0-444-63945-5.00009-X","volume":"153","author":"I Zerr","year":"2018","unstructured":"Zerr I, Parchi P (2018) Sporadic Creutzfeldt-Jakob disease. Handb Clin Neurol 153:155\u2013174. https:\/\/doi.org\/10.1016\/B978-0-444-63945-5.00009-X","journal-title":"Handb Clin Neurol"},{"issue":"10","key":"10418_CR63","doi-asserted-by":"publisher","first-page":"3043","DOI":"10.1093\/brain\/awq216","volume":"133","author":"I Nozaki","year":"2010","unstructured":"Nozaki I, Hamaguchi T, Sanjo N, Noguchi-Shinohara M, Sakai K, Nakamura Y, Sato T, Kitamoto T, Mizusawa H, Moriwaka F, Shiga Y, Kuroiwa Y, Nishizawa M, Kuzuhara S, Inuzuka T, Takeda M, Kuroda S, Abe K, Murai H, Murayama S, Tateishi J, Takumi I, Shirabe S, Harada M, Sadakane A, Yamada M (2010) Prospective 10-year surveillance of human prion diseases in Japan. Brain 133(10):3043\u20133057. https:\/\/doi.org\/10.1093\/brain\/awq216","journal-title":"Brain"},{"issue":"2","key":"10418_CR64","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/s00401-020-02168-0","volume":"140","author":"R Pascuzzo","year":"2020","unstructured":"Pascuzzo R, Oxtoby NP, Young AL, Blevins J, Castelli G, Garbarino S, Cohen ML, Schonberger LB, Gambetti P, Appleby BS, Alexander DC, Bizzi A (2020) Prion propagation estimated from brain diffusion MRI is subtype dependent in sporadic Creutzfeldt-Jakob disease. Acta Neuropathol 140(2):169\u2013181. https:\/\/doi.org\/10.1007\/s00401-020-02168-0","journal-title":"Acta Neuropathol"},{"issue":"26","key":"10418_CR65","doi-asserted-by":"publisher","first-page":"12005","DOI":"10.1073\/pnas.1004688107","volume":"107","author":"MT Bishop","year":"2010","unstructured":"Bishop MT, Will RG, Manson JC (2010) Defining sporadic Creutzfeldt-Jakob disease strains and their transmission properties. PNAS 107(26):12005\u201312010. https:\/\/doi.org\/10.1073\/pnas.1004688107","journal-title":"PNAS"},{"key":"10418_CR66","doi-asserted-by":"publisher","unstructured":"Cassard H, Huor A, Espinosa JC, Douet JY, Lugan S, Aron N, Vilette D, Delisle MB, Marin-Moreno A, Peran P, Beringue V, Torres JM, Ironside JW, Andreoletti O (2020) Prions from sporadic Creutzfeldt-Jakob disease patients propagate as strain mixtures. mBio 11(3). https:\/\/doi.org\/10.1128\/mBio.00393-20","DOI":"10.1128\/mBio.00393-20"},{"issue":"2","key":"10418_CR67","doi-asserted-by":"publisher","first-page":"e12","DOI":"10.1371\/journal.ppat.0020012","volume":"2","author":"R Nonno","year":"2006","unstructured":"Nonno R, Di Bari MA, Cardone F, Vaccari G, Fazzi P, Dell\u2019Omo G, Cartoni C, Ingrosso L, Boyle A, Galeno R, Sbriccoli M, Lipp HP, Bruce M, Pocchiari M, Agrimi U (2006) Efficient transmission and characterization of Creutzfeldt-Jakob disease strains in bank voles. PLoS Pathog 2(2):e12. https:\/\/doi.org\/10.1371\/journal.ppat.0020012","journal-title":"PLoS Pathog"},{"issue":"6","key":"10418_CR68","doi-asserted-by":"publisher","first-page":"2585","DOI":"10.1016\/S0002-9440(10)63613-9","volume":"163","author":"Y Taguchi","year":"2003","unstructured":"Taguchi Y, Mohri S, Ironside JW, Muramoto T, Kitamoto T (2003) Humanized knock-in mice expressing chimeric prion protein showed varied susceptibility to different human prions. Am J Pathol 163(6):2585\u20132593. https:\/\/doi.org\/10.1016\/S0002-9440(10)63613-9","journal-title":"Am J Pathol"},{"issue":"5","key":"10418_CR69","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1007\/s00702-018-1958-1","volume":"126","author":"OS Cohen","year":"2019","unstructured":"Cohen OS, Chapman J, Korczyn AD, Nitsan Z, Appel S, Kahana E, Rosenmann H, Hoffmann C (2019) Disease duration in E200K familial Creutzfeldt-Jakob disease is correlated with clinical, radiological, and laboratory variables. J Neural Transm (Vienna) 126(5):607\u2013611. https:\/\/doi.org\/10.1007\/s00702-018-1958-1","journal-title":"J Neural Transm (Vienna)"},{"issue":"5","key":"10418_CR70","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1111\/ene.12955","volume":"23","author":"OS Cohen","year":"2016","unstructured":"Cohen OS, Kimiagar I, Korczyn AD, Nitsan Z, Appel S, Hoffmann C, Rosenmann H, Kahana E, Chapman J (2016) Unusual presentations in patients with E200K familial Creutzfeldt-Jakob disease. Eur J Neurol 23(5):871\u2013877. https:\/\/doi.org\/10.1111\/ene.12955","journal-title":"Eur J Neurol"},{"issue":"4","key":"10418_CR71","doi-asserted-by":"publisher","first-page":"e60376","DOI":"10.1371\/journal.pone.0060376","volume":"8","author":"M Pocchiari","year":"2013","unstructured":"Pocchiari M, Poleggi A, Puopolo M, D\u2019Alessandro M, Tiple D, Ladogana A (2013) Age at Death of Creutzfeldt-Jakob disease in subsequent family generation carrying the E200K mutation of the prion protein gene. PLoS One 8(4):e60376. https:\/\/doi.org\/10.1371\/journal.pone.0060376","journal-title":"PLoS One"},{"issue":"Pt 5","key":"10418_CR72","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1093\/brain\/awm063","volume":"130","author":"U Heinemann","year":"2007","unstructured":"Heinemann U, Krasnianski A, Meissner B, Varges D, Kallenberg K, Schulz-Schaeffer WJ, Steinhoff BJ, Grasbon-Frodl EM, Kretzschmar HA, Zerr I (2007) Creutzfeldt-Jakob disease in Germany: a prospective 12-year surveillance. Brain 130(Pt 5):1350\u20131359. https:\/\/doi.org\/10.1093\/brain\/awm063","journal-title":"Brain"},{"issue":"2","key":"10418_CR73","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1007\/s00439-005-0020-1","volume":"118","author":"GG Kovacs","year":"2005","unstructured":"Kovacs GG, Puopolo M, Ladogana A, Pocchiari M, Budka H, van Duijn C, Collins SJ, Boyd A, Giulivi A, Coulthart M, Delasnerie-Laupretre N, Brandel JP, Zerr I, Kretzschmar HA, de Pedro-Cuesta J, Calero-Lara M, Glatzel M, Aguzzi A, Bishop M, Knight R, Belay G, Will R, Mitrova E, Eurocjd, (2005) Genetic prion disease: the EUROCJD experience. Hum Genet 118(2):166\u2013174. https:\/\/doi.org\/10.1007\/s00439-005-0020-1","journal-title":"Hum Genet"},{"issue":"Pt 3","key":"10418_CR74","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1099\/vir.0.007930-0","volume":"90","author":"EA Asante","year":"2009","unstructured":"Asante EA, Gowland I, Grimshaw A, Linehan JM, Smidak M, Houghton R, Osiguwa O, Tomlinson A, Joiner S, Brandner S, Wadsworth JDF, Collinge J (2009) Absence of spontaneous disease and comparative prion susceptibility of transgenic mice expressing mutant human prion proteins. J Gen Virol 90(Pt 3):546\u2013558. https:\/\/doi.org\/10.1099\/vir.0.007930-0","journal-title":"J Gen Virol"},{"issue":"1","key":"10418_CR75","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1111\/j.1750-3639.1995.tb00577.x","volume":"5","author":"J Tateishi","year":"1995","unstructured":"Tateishi J, Kitamoto T (1995) Inherited prion diseases and transmission to rodents. Brain Pathol 5(1):53\u201359. https:\/\/doi.org\/10.1111\/j.1750-3639.1995.tb00577.x","journal-title":"Brain Pathol"},{"issue":"5","key":"10418_CR76","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1111\/neup.12013","volume":"33","author":"Y Iwasaki","year":"2013","unstructured":"Iwasaki Y, Yokoi F, Tatsumi S, Mimuro M, Iwai K, Kitamoto T, Yoshida M (2013) An autopsied case of Creutzfeldt-Jakob disease with mutation in the prion protein gene codon 232 and type 1+2 prion protein. Neuropathology 33(5):568\u2013575. https:\/\/doi.org\/10.1111\/neup.12013","journal-title":"Neuropathology"},{"issue":"5","key":"10418_CR77","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1007\/s004010050544","volume":"92","author":"MZ Hoque","year":"1996","unstructured":"Hoque MZ, Kitamoto T, Furukawa H, Muramoto T, Tateishi J (1996) Mutation in the prion protein gene at codon 232 in Japanese patients with Creutzfeldt-Jakob disease: a clinicopathological, immunohistochemical and transmission study. Acta Neuropathol 92(5):441\u2013446. https:\/\/doi.org\/10.1007\/s004010050544","journal-title":"Acta Neuropathol"},{"issue":"6","key":"10418_CR78","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1111\/j.1440-1789.2009.01016.x","volume":"29","author":"T Hama","year":"2009","unstructured":"Hama T, Iwasaki Y, Niwa H, Yoshida M, Hashizume Y, Kitamoto T, Murakami N, Sobue G (2009) An autopsied case of panencephalopathic-type Creutzfeldt-Jakob disease with mutation in the prion protein gene at codon 232 and type 1 prion protein. Neuropathology 29(6):727\u2013734. https:\/\/doi.org\/10.1111\/j.1440-1789.2009.01016.x","journal-title":"Neuropathology"},{"issue":"11","key":"10418_CR79","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1007\/s00415-007-0540-9","volume":"254","author":"Y Shiga","year":"2007","unstructured":"Shiga Y, Satoh K, Kitamoto T, Kanno S, Nakashima I, Sato S, Fujihara K, Takata H, Nobukuni K, Kuroda S, Takano H, Umeda Y, Konno H, Nagasato K, Satoh A, Matsuda Y, Hidaka M, Takahashi H, Sano Y, Kim K, Konishi T, Doh-ura K, Sato T, Sasaki K, Nakamura Y, Yamada M, Mizusawa H, Itoyama Y (2007) Two different clinical phenotypes of Creutzfeldt-Jakob disease with a M232R substitution. J Neurol 254(11):1509\u20131517. https:\/\/doi.org\/10.1007\/s00415-007-0540-9","journal-title":"J Neurol"},{"issue":"1","key":"10418_CR80","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1111\/j.1750-3639.1995.tb00576.x","volume":"5","author":"P Gambetti","year":"1995","unstructured":"Gambetti P, Parchi P, Petersen RB, Chen SG, Lugaresi E (1995) Fatal familial insomnia and familial Creutzfeldt-Jakob disease: clinical, pathological and molecular features. Brain Pathol 5(1):43\u201351. https:\/\/doi.org\/10.1111\/j.1750-3639.1995.tb00576.x","journal-title":"Brain Pathol"},{"issue":"5","key":"10418_CR81","doi-asserted-by":"publisher","first-page":"e004968","DOI":"10.1136\/bmjopen-2014-004968","volume":"4","author":"T Qina","year":"2014","unstructured":"Qina T, Sanjo N, Hizume M, Higuma M, Tomita M, Atarashi R, Satoh K, Nozaki I, Hamaguchi T, Nakamura Y, Kobayashi A, Kitamoto T, Murayama S, Murai H, Yamada M, Mizusawa H (2014) Clinical features of genetic Creutzfeldt-Jakob disease with V180I mutation in the prion protein gene. BMJ Open 4(5):e004968. https:\/\/doi.org\/10.1136\/bmjopen-2014-004968","journal-title":"BMJ Open"},{"key":"10418_CR82","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/B978-0-444-63945-5.00011-8","volume":"153","author":"JP Brandel","year":"2018","unstructured":"Brandel JP, Knight R (2018) Variant Creutzfeldt-Jakob disease. Handb Clin Neurol 153:191\u2013205. https:\/\/doi.org\/10.1016\/B978-0-444-63945-5.00011-8","journal-title":"Handb Clin Neurol"},{"key":"10418_CR83","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1007\/978-94-007-5416-4_17","volume":"65","author":"B Sikorska","year":"2012","unstructured":"Sikorska B, Liberski PP (2012) Human prion diseases: from Kuru to variant Creutzfeldt-Jakob disease. Subcell Biochem 65:457\u2013496. https:\/\/doi.org\/10.1007\/978-94-007-5416-4_17","journal-title":"Subcell Biochem"},{"issue":"5","key":"10418_CR84","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1054\/jocn.2001.0919","volume":"8","author":"S Collins","year":"2001","unstructured":"Collins S, McLean CA, Masters CL (2001) Gerstmann-Straussler-Scheinker syndrome, fatal familial insomnia, and kuru: a review of these less common human transmissible spongiform encephalopathies. J Clin Neuro 8(5):387\u2013397. https:\/\/doi.org\/10.1054\/jocn.2001.0919","journal-title":"J Clin Neuro"},{"issue":"6539","key":"10418_CR85","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1038\/376434a0","volume":"376","author":"J Tateishi","year":"1995","unstructured":"Tateishi J, Brown P, Kitamoto T, Hoque ZM, Roos R, Wollman R, Cervenakova L, Gajdusek DC (1995) First experimental transmission of fatal familial insomnia. Nature 376(6539):434\u2013435. https:\/\/doi.org\/10.1038\/376434a0","journal-title":"Nature"},{"issue":"6","key":"10418_CR86","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1002\/ana.21420","volume":"63","author":"P Gambetti","year":"2008","unstructured":"Gambetti P, Dong Z, Yuan J, Xiao X, Zheng M, Alshekhlee A, Castellani R, Cohen M, Barria MA, Gonzalez-Romero D, Belay ED, Schonberger LB, Marder K, Harris C, Burke JR, Montine T, Wisniewski T, Dickson DW, Soto C, Hulette CM, Mastrianni JA, Kong Q, Zou WQ (2008) A novel human disease with abnormal prion protein sensitive to protease. Ann Neurol 63(6):697\u2013708. https:\/\/doi.org\/10.1002\/ana.21420","journal-title":"Ann Neurol"},{"issue":"2","key":"10418_CR87","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1111\/neup.12538","volume":"39","author":"M Aizpurua","year":"2019","unstructured":"Aizpurua M, Selvackadunco S, Yull H, Kipps CM, Ironside JW, Bodi I (2019) Variably protease-sensitive prionopathy mimicking frontotemporal dementia. Neuropathology 39(2):135\u2013140. https:\/\/doi.org\/10.1111\/neup.12538","journal-title":"Neuropathology"},{"key":"10418_CR88","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/1471-2377-10-99","volume":"10","author":"AB Rodriguez-Martinez","year":"2010","unstructured":"Rodriguez-Martinez AB, Garrido JM, Zarranz JJ, Arteagoitia JM, de Pancorbo MM, Atares B, Bilbao MJ, Ferrer I, Juste RA (2010) A novel form of human disease with a protease-sensitive prion protein and heterozygosity methionine\/valine at codon 129: case report. BMC Neurol 10:99. https:\/\/doi.org\/10.1186\/1471-2377-10-99","journal-title":"BMC Neurol"},{"key":"10418_CR89","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/B978-0-444-63945-5.00010-6","volume":"153","author":"S Notari","year":"2018","unstructured":"Notari S, Appleby BS, Gambetti P (2018) Variably protease-sensitive prionopathy. Handb Clin Neurol 153:175\u2013190. https:\/\/doi.org\/10.1016\/B978-0-444-63945-5.00010-6","journal-title":"Handb Clin Neurol"},{"issue":"3","key":"10418_CR90","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1590\/s0004-282x2011000400002","volume":"69","author":"GR Rodrigues","year":"2011","unstructured":"Rodrigues GR, Walker RH, Bader B, Danek A, Brice A, Cazeneuve C, Russaouen O, Lopes-Cendes I, Marques W Jr, Tumas V (2011) Clinical and genetic analysis of 29 Brazilian patients with Huntington\u2019s disease-like phenotype. Arq Neuropsiquiatr 69(3):419\u2013423. https:\/\/doi.org\/10.1590\/s0004-282x2011000400002","journal-title":"Arq Neuropsiquiatr"},{"issue":"2","key":"10418_CR91","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1111\/j.1750-3639.1996.tb00796.x","volume":"6","author":"B Ghetti","year":"1996","unstructured":"Ghetti B, Piccardo P, Frangione B, Bugiani O, Giaccone G, Young K, Prelli F, Farlow MR, Dlouhy SR, Tagliavini F (1996) Prion protein amyloidosis. Brain Pathol 6(2):127\u2013145. https:\/\/doi.org\/10.1111\/j.1750-3639.1996.tb00796.x","journal-title":"Brain Pathol"},{"issue":"6","key":"10418_CR92","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1080\/19336896.2016.1239686","volume":"10","author":"R Nonno","year":"2016","unstructured":"Nonno R, Angelo Di Bari M, Agrimi U, Pirisinu L (2016) Transmissibility of Gerstmann-Straussler-Scheinker syndrome in rodent models: new insights into the molecular underpinnings of prion infectivity. Prion 10(6):421\u2013433. https:\/\/doi.org\/10.1080\/19336896.2016.1239686","journal-title":"Prion"},{"issue":"3","key":"10418_CR93","doi-asserted-by":"publisher","first-page":"188","DOI":"10.4161\/viru.2.3.15880","volume":"2","author":"K Miyazawa","year":"2011","unstructured":"Miyazawa K, Emmerling K, Manuelidis L (2011) Replication and spread of CJD, kuru and scrapie agents in vivo and in cell culture. Virulence 2(3):188\u2013199. https:\/\/doi.org\/10.4161\/viru.2.3.15880","journal-title":"Virulence"},{"issue":"6","key":"10418_CR94","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1002\/acn3.568","volume":"5","author":"S Capellari","year":"2018","unstructured":"Capellari S, Baiardi S, Rinaldi R, Bartoletti-Stella A, Graziano C, Piras S, Calandra-Buonaura G, D\u2019Angelo R, Terziotti C, Lodi R, Donadio V, Pironi L, Cortelli P, Parchi P (2018) Two novel PRNP truncating mutations broaden the spectrum of prion amyloidosis. Ann Clin Transl Neurol 5(6):777\u2013783. https:\/\/doi.org\/10.1002\/acn3.568","journal-title":"Ann Clin Transl Neurol"},{"issue":"1","key":"10418_CR95","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1007\/s12035-015-9662-8","volume":"54","author":"YM Sun","year":"2017","unstructured":"Sun YM, Zhang YB, Wu ZY (2017) Huntington\u2019s disease: relationship between phenotype and genotype. Mol Neurobiol 54(1):342\u2013348. https:\/\/doi.org\/10.1007\/s12035-015-9662-8","journal-title":"Mol Neurobiol"},{"issue":"17","key":"10418_CR96","doi-asserted-by":"publisher","first-page":"e1939","DOI":"10.1212\/WNL.0000000000007355","volume":"92","author":"A Tereshchenko","year":"2019","unstructured":"Tereshchenko A, Magnotta V, Epping E, Mathews K, Espe-Pfeifer P, Martin E, Dawson J, Duan W, Nopoulos P (2019) Brain structure in juvenile-onset Huntington disease. Neurology 92(17):e1939\u2013e1947. https:\/\/doi.org\/10.1212\/WNL.0000000000007355","journal-title":"Neurology"},{"issue":"4","key":"10418_CR97","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1111\/j.1399-0004.2006.00668.x","volume":"70","author":"A Semaka","year":"2006","unstructured":"Semaka A, Creighton S, Warby S, Hayden MR (2006) Predictive testing for Huntington disease: interpretation and significance of intermediate alleles. Clin Genet 70(4):283\u2013294. https:\/\/doi.org\/10.1111\/j.1399-0004.2006.00668.x","journal-title":"Clin Genet"},{"issue":"1","key":"10418_CR98","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1002\/mds.870100116","volume":"10","author":"J Jankovic","year":"1995","unstructured":"Jankovic J, Ashizawa T (1995) Tourettism associated with Huntington\u2019s disease. Mov Disord 10(1):103\u2013105. https:\/\/doi.org\/10.1002\/mds.870100116","journal-title":"Mov Disord"},{"issue":"4","key":"10418_CR99","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1111\/j.1600-0404.2008.01091.x","volume":"119","author":"E Savva","year":"2009","unstructured":"Savva E, Schnorf H, Burkhard PR (2009) Restless legs syndrome: an early manifestation of Huntington\u2019s disease? Acta Neurol Scand 119(4):274\u2013276. https:\/\/doi.org\/10.1111\/j.1600-0404.2008.01091.x","journal-title":"Acta Neurol Scand"},{"issue":"4","key":"10418_CR100","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1097\/NRL.0000000000000023","volume":"19","author":"C Colosimo","year":"2015","unstructured":"Colosimo C (2015) A case of atypical adult-onset tic disorder. Neurologist 19(4):99\u2013100. https:\/\/doi.org\/10.1097\/NRL.0000000000000023","journal-title":"Neurologist"},{"issue":"4","key":"10418_CR101","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1111\/j.1399-0004.2012.01927.x","volume":"83","author":"Y Dong","year":"2013","unstructured":"Dong Y, Sun YM, Liu ZJ, Ni W, Shi SS, Wu ZY (2013) Chinese patients with Huntington\u2019s disease initially presenting with spinocerebellar ataxia. Clin Genet 83(4):380\u2013383. https:\/\/doi.org\/10.1111\/j.1399-0004.2012.01927.x","journal-title":"Clin Genet"},{"key":"10418_CR102","doi-asserted-by":"publisher","first-page":"571843","DOI":"10.3389\/fneur.2020.571843","volume":"11","author":"GL Franklin","year":"2020","unstructured":"Franklin GL, Camargo CHF, Meira AT, Pavanelli GM, Milano SS, Germiniani FB, Lima NSC, Raskin S, Barsottini OGP, Pedroso JL, Maggi FA, Tumas V, de Carvalho PM, de Oliveira AC, Braga B, Souza LC, Guimaraes RP, Piovesana LG, Lopes-Cendes IT, de Azevedo PC, Franca MC Jr, Martinez ARM, Teive HAG (2020) Is ataxia an underestimated symptom of Huntington\u2019s disease? Front Neurol 11:571843. https:\/\/doi.org\/10.3389\/fneur.2020.571843","journal-title":"Front Neurol"},{"key":"10418_CR103","doi-asserted-by":"publisher","first-page":"696953","DOI":"10.1155\/2011\/696953","volume":"2011","author":"A Ciammola","year":"2011","unstructured":"Ciammola A, Sassone J, Poletti B, Mencacci N, Benti R, Silani V (2011) Atypical parkinsonism revealing a late onset, rigid and akinetic form of Huntington\u2019s disease. Case Rep Neurol Med 2011:696953. https:\/\/doi.org\/10.1155\/2011\/696953","journal-title":"Case Rep Neurol Med"},{"issue":"2","key":"10418_CR104","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1136\/jnnp.68.2.238","volume":"68","author":"I Reuter","year":"2000","unstructured":"Reuter I, Hu MT, Andrews TC, Brooks DJ, Clough C, Chaudhuri KR (2000) Late onset levodopa responsive Huntington\u2019s disease with minimal chorea masquerading as Parkinson plus syndrome. J Neurol Neurosurg Psychiatry 68(2):238\u2013241. https:\/\/doi.org\/10.1136\/jnnp.68.2.238","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1","key":"10418_CR105","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1002\/ana.410260112","volume":"26","author":"RM Zweig","year":"1989","unstructured":"Zweig RM, Koven SJ, Hedreen JC, Maestri NE, Kazazian HH Jr, Folstein SE (1989) Linkage to the Huntington\u2019s disease locus in a family with unusual clinical and pathological features. Ann Neurol 26(1):78\u201384. https:\/\/doi.org\/10.1002\/ana.410260112","journal-title":"Ann Neurol"},{"key":"10418_CR106","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/7854_2014_354","volume":"22","author":"HJ Waldvogel","year":"2015","unstructured":"Waldvogel HJ, Kim EH, Tippett LJ, Vonsattel JP, Faull RL (2015) The neuropathology of Huntington\u2019s disease. Curr Top Behav Neurosci 22:33\u201380. https:\/\/doi.org\/10.1007\/7854_2014_354","journal-title":"Curr Top Behav Neurosci"},{"issue":"9","key":"10418_CR107","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1038\/ncpneuro0606","volume":"3","author":"SA Schneider","year":"2007","unstructured":"Schneider SA, Walker RH, Bhatia KP (2007) The Huntington\u2019s disease-like syndromes: what to consider in patients with a negative Huntington\u2019s disease gene test. Nat Clin Pract Neurol 3(9):517\u2013525. https:\/\/doi.org\/10.1038\/ncpneuro0606","journal-title":"Nat Clin Pract Neurol"},{"issue":"4","key":"10418_CR108","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1111\/cge.12283","volume":"86","author":"RM Castilhos","year":"2014","unstructured":"Castilhos RM, Souza AF, Furtado GV, Gheno TC, Silva AL, Vargas FR, Lima MA, Barsottini O, Pedroso JL, Godeiro C Jr, Salarini D, Pereira ET, Lin K, Toralles MB, Saute JA, Rieder CR, Quintas M, Sequeiros J, Alonso I, Saraiva-Pereira ML, Jardim LB (2014) Huntington disease and Huntington disease-like in a case series from Brazil. Clin Genet 86(4):373\u2013377. https:\/\/doi.org\/10.1111\/cge.12283","journal-title":"Clin Genet"},{"issue":"5","key":"10418_CR109","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1136\/jnnp.68.5.672","volume":"68","author":"I Vuillaume","year":"2000","unstructured":"Vuillaume I, Meynieu P, Schraen-Maschke S, Destee A, Sablonniere B (2000) Absence of unidentified CAG repeat expansion in patients with Huntington\u2019s disease-like phenotype. J Neurol Neurosurg Psychiatry 68(5):672\u2013675. https:\/\/doi.org\/10.1136\/jnnp.68.5.672","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"3","key":"10418_CR110","doi-asserted-by":"publisher","first-page":"283","DOI":"10.3233\/JHD-200398","volume":"9","author":"J Kaur","year":"2020","unstructured":"Kaur J, Parveen S, Shamim U, Sharma P, Suroliya V, Sonkar AK, Ahmad I, Garg J, Anand KS, Laskar S, Chowdhury D, Kushwaha S, Goyal V, Srivastava AK, Singh G, Faruq M (2020) Investigations of Huntington\u2019s disease and Huntington\u2019s disease-like syndromes in Indian choreatic patients. J Huntingtons Dis 9(3):283\u2013289. https:\/\/doi.org\/10.3233\/JHD-200398","journal-title":"J Huntingtons Dis"},{"issue":"7","key":"10418_CR111","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1002\/ajmg.b.32332","volume":"168","author":"A Krause","year":"2015","unstructured":"Krause A, Mitchell C, Essop F, Tager S, Temlett J, Stevanin G, Ross C, Rudnicki D, Margolis R (2015) Junctophilin 3 (JPH3) expansion mutations causing Huntington disease like 2 (HDL2) are common in South African patients with African ancestry and a Huntington disease phenotype. Am J Med Genet B Neuropsychiatry Genet 168(7):573\u2013585. https:\/\/doi.org\/10.1002\/ajmg.b.32332","journal-title":"Am J Med Genet B Neuropsychiatry Genet"},{"key":"10418_CR112","doi-asserted-by":"publisher","unstructured":"Koutsis G, Karadima G, Kartanou C, Kladi A, Panas M (2015) C9ORF72 hexanucleotide repeat expansions are a frequent cause of Huntington disease phenocopies in the Greek population. Neurobiol Aging 36 (1):547 e513\u2013546. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2014.08.020","DOI":"10.1016\/j.neurobiolaging.2014.08.020"},{"issue":"4","key":"10418_CR113","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1212\/WNL.0000000000000061","volume":"82","author":"DJ Hensman Moss","year":"2014","unstructured":"Hensman Moss DJ, Poulter M, Beck J, Hehir J, Polke JM, Campbell T, Adamson G, Mudanohwo E, McColgan P, Haworth A, Wild EJ, Sweeney MG, Houlden H, Mead S, Tabrizi SJ (2014) C9orf72 expansions are the most common genetic cause of Huntington disease phenocopies. Neurology 82(4):292\u2013299. https:\/\/doi.org\/10.1212\/WNL.0000000000000061","journal-title":"Neurology"},{"issue":"8","key":"10418_CR114","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1007\/s10038-006-0001-9","volume":"51","author":"MDC Costa","year":"2006","unstructured":"Costa MDC, Teixeira-Castro A, Constante M, Magalhaes M, Magalhaes P, Cerqueira J, Vale J, Passao V, Barbosa C, Robalo C, Coutinho P, Barros J, Santos MM, Sequeiros J, Maciel P (2006) Exclusion of mutations in the PRNP, JPH3, TBP, ATN1, CREBBP, POU3F2 and FTL genes as a cause of disease in Portuguese patients with a Huntington-like phenotype. J Hum Genet 51(8):645\u2013651. https:\/\/doi.org\/10.1007\/s10038-006-0001-9","journal-title":"J Hum Genet"},{"issue":"6","key":"10418_CR115","doi-asserted-by":"publisher","first-page":"501","DOI":"10.4161\/pri.27260","volume":"7","author":"M Paucar","year":"2013","unstructured":"Paucar M, Xiang F, Moore R, Walker R, Winnberg E, Svenningsson P (2013) Genotype-phenotype analysis in inherited prion disease with eight octapeptide repeat insertional mutation. Prion 7(6):501\u2013510. https:\/\/doi.org\/10.4161\/pri.27260","journal-title":"Prion"},{"issue":"Pt 12","key":"10418_CR116","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1093\/brain\/122.12.2375","volume":"122","author":"JL Laplanche","year":"1999","unstructured":"Laplanche JL, Hachimi KH, Durieux I, Thuillet P, Defebvre L, Delasnerie-Laupretre N, Peoc\u2019h K, Foncin JF, Destee A (1999) Prominent psychiatric features and early onset in an inherited prion disease with a new insertional mutation in the prion protein gene. Brain 122(Pt 12):2375\u20132386. https:\/\/doi.org\/10.1093\/brain\/122.12.2375","journal-title":"Brain"},{"key":"10418_CR117","doi-asserted-by":"publisher","first-page":"5","DOI":"10.5334\/tohm.61","volume":"10","author":"D Rikos","year":"2020","unstructured":"Rikos D, Marogianni C, Provatas A, Bourinaris T, Arnaoutoglou M, Stathis P, Patrinos GP, Dardiotis E, Hadjigeorgiou GM, Xiromerisiou G (2020) Screening for the C9ORF72 expansion in Greek Huntington Disease phenocopies and controls and meta-analysis of current data. Tremor Other Hyperkinet Mov (N Y) 10:5. https:\/\/doi.org\/10.5334\/tohm.61","journal-title":"Tremor Other Hyperkinet Mov (N Y)"},{"issue":"4","key":"10418_CR118","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1097\/NEN.0b013e31816b4aee","volume":"67","author":"DD Rudnicki","year":"2008","unstructured":"Rudnicki DD, Pletnikova O, Vonsattel JP, Ross CA, Margolis RL (2008) A comparison of huntington disease and huntington disease-like 2 neuropathology. J Neuropathol Exp Neurol 67(4):366\u2013374. https:\/\/doi.org\/10.1097\/NEN.0b013e31816b4aee","journal-title":"J Neuropathol Exp Neurol"},{"issue":"3","key":"10418_CR119","first-page":"203","volume":"42","author":"A Sulek-Piatkowska","year":"2008","unstructured":"Sulek-Piatkowska A, Krysa W, Zdzienicka E, Szirkowiec W, Hoffman-Zacharska D, Rajkiewicz M, Fidzianska E, Kowalska G, Zaremba J (2008) Searching for mutation in the JPH3, ATN1 and TBP genes in Polish patients suspected of Huntington\u2019s disease and without mutation in the IT15 gene. Neurol Neurochir Pol 42(3):203\u2013209","journal-title":"Neurol Neurochir Pol"},{"issue":"1","key":"10418_CR120","first-page":"85","volume":"20","author":"AY Al-Tahan","year":"1999","unstructured":"Al-Tahan AY, Divakaran MP, Kambouris M, Bohlega S, Salih M, Ogunniyi A, Al-Ghanmi H (1999) A novel autosomal recessive \u201cHuntington\u2019s disease-like\u201d neurodegenerative disorder in a Saudi family. Saudi Med J 20(1):85\u201389","journal-title":"Saudi Med J"},{"issue":"2","key":"10418_CR121","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1086\/302744","volume":"66","author":"M Kambouris","year":"2000","unstructured":"Kambouris M, Bohlega S, Al-Tahan A, Meyer BF (2000) Localization of the gene for a novel autosomal recessive neurodegenerative Huntington-like disorder to 4p153. Am J Hum Genet 66(2):445\u2013452. https:\/\/doi.org\/10.1086\/302744","journal-title":"Am J Hum Genet"},{"issue":"3","key":"10418_CR122","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1002\/ana.10676","volume":"54","author":"A Rolfs","year":"2003","unstructured":"Rolfs A, Koeppen AH, Bauer I, Bauer P, Buhlmann S, Topka H, Schols L, Riess O (2003) Clinical features and neuropathology of autosomal dominant spinocerebellar ataxia (SCA17). Ann Neurol 54(3):367\u2013375. https:\/\/doi.org\/10.1002\/ana.10676","journal-title":"Ann Neurol"},{"key":"10418_CR123","unstructured":"Toyoshima Y, Onodera O, Yamada M, Tsuji S, Takahashi H (1993) Spinocerebellar ataxia type 17. In: Adam MP, Ardinger HH, Pagon RA et al (eds) Gene reviews (R). Seattle, WA"},{"issue":"Pt 3","key":"10418_CR124","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1093\/brain\/121.3.459","volume":"121","author":"P Giunti","year":"1998","unstructured":"Giunti P, Sabbadini G, Sweeney MG, Davis MB, Veneziano L, Mantuano E, Federico A, Plasmati R, Frontali M, Wood NW (1998) The role of the SCA2 trinucleotide repeat expansion in 89 autosomal dominant cerebellar ataxia families. Frequency, clinical and genetic correlates. Brain 121(Pt 3):459\u2013467. https:\/\/doi.org\/10.1093\/brain\/121.3.459","journal-title":"Brain"},{"issue":"1","key":"10418_CR125","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/s00401-007-0287-5","volume":"115","author":"M Yamada","year":"2008","unstructured":"Yamada M, Sato T, Tsuji S, Takahashi H (2008) CAG repeat disorder models and human neuropathology: similarities and differences. Acta Neuropathol 115(1):71\u201386. https:\/\/doi.org\/10.1007\/s00401-007-0287-5","journal-title":"Acta Neuropathol"},{"key":"10418_CR126","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.jns.2018.04.031","volume":"390","author":"FK Baine","year":"2018","unstructured":"Baine FK, Peerbhai N, Krause A (2018) A study of Huntington disease-like syndromes in black South African patients reveals a single SCA2 mutation and a unique distribution of normal alleles across five repeat loci. J Neurol Sci 390:200\u2013204. https:\/\/doi.org\/10.1016\/j.jns.2018.04.031","journal-title":"J Neurol Sci"},{"issue":"5","key":"10418_CR127","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1002\/mds.21915","volume":"23","author":"EJ Wild","year":"2008","unstructured":"Wild EJ, Mudanohwo EE, Sweeney MG, Schneider SA, Beck J, Bhatia KP, Rossor MN, Davis MB, Tabrizi SJ (2008) Huntington\u2019s disease phenocopies are clinically and genetically heterogeneous. Mov Disord 23(5):716\u2013720. https:\/\/doi.org\/10.1002\/mds.21915","journal-title":"Mov Disord"},{"issue":"3\u20134","key":"10418_CR128","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/s0361-9230(01)00596-2","volume":"56","author":"SE Holmes","year":"2001","unstructured":"Holmes SE, Hearn EO, Ross CA, Margolis RL (2001) SCA12: an unusual mutation leads to an unusual spinocerebellar ataxia. Brain Res Bull 56(3\u20134):397\u2013403. https:\/\/doi.org\/10.1016\/s0361-9230(01)00596-2","journal-title":"Brain Res Bull"},{"issue":"8","key":"10418_CR129","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1002\/mds.26679","volume":"31","author":"E Groppo","year":"2016","unstructured":"Groppo E, Armaroli A, Selvatici R, Gualandi F, Sensi M (2016) Huntington\u2019s disease-like presentation in Spinocerebellar ataxia type 12. Mov Disord 31(8):1248\u20131249. https:\/\/doi.org\/10.1002\/mds.26679","journal-title":"Mov Disord"},{"issue":"13","key":"10418_CR130","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1002\/mds.26348","volume":"30","author":"EE O'Hearn","year":"2015","unstructured":"O\u2019Hearn EE, Hwang HS, Holmes SE, Rudnicki DD, Chung DW, Seixas AI, Cohen RL, Ross CA, Trojanowski JQ, Pletnikova O, Troncoso JC, Margolis RL (2015) Neuropathology and cellular pathogenesis of spinocerebellar ataxia type 12. Mov Disord 30(13):1813\u20131824. https:\/\/doi.org\/10.1002\/mds.26348","journal-title":"Mov Disord"},{"issue":"4","key":"10418_CR131","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1002\/mds.870120408","volume":"12","author":"MW Becher","year":"1997","unstructured":"Becher MW, Rubinsztein DC, Leggo J, Wagster MV, Stine OC, Ranen NG, Franz ML, Abbott MH, Sherr M, MacMillan JC, Barron L, Porteous M, Harper PS, Ross CA (1997) Dentatorubral and pallidoluysian atrophy (DRPLA). Clinical and neuropathological findings in genetically confirmed North American and European pedigrees. Mov Disord 12(4):519\u2013530. https:\/\/doi.org\/10.1002\/mds.870120408","journal-title":"Mov Disord"},{"key":"10418_CR132","doi-asserted-by":"publisher","first-page":"577","DOI":"10.7916\/D81N9HST","volume":"8","author":"LS Carroll","year":"2018","unstructured":"Carroll LS, Massey TH, Wardle M, Peall KJ (2018) Dentatorubral\u2013pallidoluysian atrophy: an update. Tremor Other Hyperkinet Mov (NY) 8:577. https:\/\/doi.org\/10.7916\/D81N9HST","journal-title":"Tremor Other Hyperkinet Mov (NY)"},{"issue":"1","key":"10418_CR133","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1002\/acn3.50966","volume":"7","author":"G Naeije","year":"2020","unstructured":"Naeije G, Wens V, Coquelet N, Sjogard M, Goldman S, Pandolfo M, De Tiege XP (2020) Age of onset determines intrinsic functional brain architecture in Friedreich ataxia. Ann Clin Transl Neurol 7(1):94\u2013104. https:\/\/doi.org\/10.1002\/acn3.50966","journal-title":"Ann Clin Transl Neurol"},{"issue":"2","key":"10418_CR134","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1097\/NEN.0b013e31827e5762","volume":"72","author":"AH Koeppen","year":"2013","unstructured":"Koeppen AH, Mazurkiewicz JE (2013) Friedreich ataxia: neuropathology revised. J Neuropathol Exp Neurol 72(2):78\u201390. https:\/\/doi.org\/10.1097\/NEN.0b013e31827e5762","journal-title":"J Neuropathol Exp Neurol"},{"issue":"11","key":"10418_CR135","doi-asserted-by":"publisher","first-page":"2215","DOI":"10.1007\/s00415-016-8252-7","volume":"263","author":"LP Selvadurai","year":"2016","unstructured":"Selvadurai LP, Harding IH, Corben LA, Stagnitti MR, Storey E, Egan GF, Delatycki MB, Georgiou-Karistianis N (2016) Cerebral and cerebellar grey matter atrophy in Friedreich ataxia: the IMAGE-FRDA study. J Neurol 263(11):2215\u20132223. https:\/\/doi.org\/10.1007\/s00415-016-8252-7","journal-title":"J Neurol"},{"key":"10418_CR136","doi-asserted-by":"publisher","first-page":"355","DOI":"10.7916\/D8KK9BHF","volume":"6","author":"N Kumar","year":"2016","unstructured":"Kumar N, Rizek P, Jog M (2016) Neuroferritinopathy: pathophysiology, presentation, differential diagnoses and management. Tremor Other Hyperkinet Mov (NY) 6:355. https:\/\/doi.org\/10.7916\/D8KK9BHF","journal-title":"Tremor Other Hyperkinet Mov (NY)"},{"issue":"1","key":"10418_CR137","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1002\/acn3.511","volume":"5","author":"H Garcia-Moreno","year":"2018","unstructured":"Garcia-Moreno H, Fassihi H, Sarkany RPE, Phukan J, Warner T, Lehmann AR, Giunti P (2018) Xeroderma pigmentosum is a definite cause of Huntington\u2019s disease-like syndrome. Ann Clin Transl Neurol 5(1):102\u2013108. https:\/\/doi.org\/10.1002\/acn3.511","journal-title":"Ann Clin Transl Neurol"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-021-10418-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-021-10418-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-021-10418-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,11]],"date-time":"2021-08-11T16:14:46Z","timestamp":1628698486000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-021-10418-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,24]]},"references-count":137,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["10418"],"URL":"https:\/\/doi.org\/10.1007\/s00415-021-10418-8","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,24]]},"assertion":[{"value":"15 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 January 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 January 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interests"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}